Michael Zinda

Insider Reports History

Entity
Individual
Location
C/O Repare Therapeutics Inc., 7210 Frederick Banting, Suite 100, St Laurent, Quebec, Canada
Signature
/s/ Steve Forte, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Zinda:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Repare Therapeutics Inc. EVP, CHIEF SCIENTIFIC OFFICER Common Shares 71.9K $335K $4.66 Apr 1, 2024 Direct
Repare Therapeutics Inc. EVP, CHIEF SCIENTIFIC OFFICER Employee Stock Option (right to buy) 85K Mar 1, 2024 Direct

Insider Reports Filed by Michael Zinda

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RPTX Repare Therapeutics Inc. Mar 28, 2024 2 -$4K 4 Apr 1, 2024 EVP, CHIEF SCIENTIFIC OFFICER
RPTX Repare Therapeutics Inc. Mar 25, 2024 3 -$6.3K 4 Mar 27, 2024 EVP, CHIEF SCIENTIFIC OFFICER
RPTX Repare Therapeutics Inc. Mar 1, 2024 2 $0 4 Mar 4, 2024 EVP, CHIEF SCIENTIFIC OFFICER
RPTX Repare Therapeutics Inc. Jun 7, 2023 2 -$42.6K 4 Jun 9, 2023 EVP, Chief Scientific Officer
RPTX Repare Therapeutics Inc. Jun 6, 2023 1 -$14.4K 4 Jun 7, 2023 EVP, Chief Scientific Officer
RPTX Repare Therapeutics Inc. Jan 30, 2023 2 $0 4 Feb 1, 2023 EVP, Chief Scientific Officer
RPTX Repare Therapeutics Inc. Mar 15, 2022 1 -$6.02K 4 Mar 16, 2022 EVP, Chief Science Officer
RPTX Repare Therapeutics Inc. Jan 18, 2022 1 $0 4 Jan 20, 2022 EVP, Chief Science Officer
RPTX Repare Therapeutics Inc. Nov 23, 2021 8 $91.9K 4 Dec 6, 2021 EVP, Chief Science Officer
RPTX Repare Therapeutics Inc. Nov 15, 2021 2 -$547K 4 Nov 17, 2021 EVP, Chief Science Officer
RPTX Repare Therapeutics Inc. Aug 16, 2021 2 -$510K 4 Aug 20, 2021 EVP, Chief Science Officer
RPTX Repare Therapeutics Inc. May 17, 2021 3 -$491K 4 May 18, 2021 EVP, Chief Science Officer